ECZEMA, ATOPIC
Clinical trials for ECZEMA, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new ECZEMA, ATOPIC trials appear
Sign up with your email to follow new studies for ECZEMA, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema drug shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new medicine called camoteskimab for adults with moderate-to-severe atopic dermatitis (eczema). About 280 people will receive either the drug or a placebo to see if it reduces skin redness, swelling, and itching. The main goal is to measure improvement in eczem…
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Symptom relief
Last updated May 26, 2026 11:09 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study tests a new daily pill, soquelitinib, in 200 adults with moderate to severe atopic dermatitis (eczema). Participants take the drug or a placebo for 12 weeks. Doctors track skin improvements and side effects to see if the drug is safe and works better than a dummy pill.
Matched conditions: ECZEMA, ATOPIC
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC